1. Home
  2. MBBC vs NTRB Comparison

MBBC vs NTRB Comparison

Compare MBBC & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

BUY

Current Price

$14.97

Market Cap

40.2M

Sector

Finance

ML Signal

BUY

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.00

Market Cap

44.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBBC
NTRB
Founded
1902
2016
Country
United States
United States
Employees
35
3
Industry
Banks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
44.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MBBC
NTRB
Price
$14.97
$4.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.0K
6.2K
Earning Date
05-13-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.17
Revenue Next Year
N/A
$3,394.36
P/E Ratio
$47.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.94
$3.42
52 Week High
$14.64
$11.68

Technical Indicators

Market Signals
Indicator
MBBC
NTRB
Relative Strength Index (RSI) 61.62 49.55
Support Level $12.93 $3.51
Resistance Level N/A $4.50
Average True Range (ATR) 0.41 0.20
MACD 0.07 0.02
Stochastic Oscillator 99.47 45.79

Price Performance

Historical Comparison
MBBC
NTRB

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: